Harris Associates discloses 6.2% Zimmer Biomet (ZBH) stake in Schedule 13G filing
Rhea-AI Filing Summary
Harris Associates has disclosed a sizable stake in Zimmer Biomet Holdings, Inc. common stock. Through Harris Associates L.P. and Harris Associates, Inc., the firm reports beneficial ownership of 12,264,703 shares, representing 6.2% of Zimmer Biomet’s common stock.
Harris reports sole voting power over 11,892,571 shares and sole dispositive power over 12,264,703 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Zimmer Biomet.
Positive
- None.
Negative
- None.
Insights
Harris Associates reports a 6.2% passive stake in Zimmer Biomet.
Harris Associates L.P. and Harris Associates, Inc. report beneficial ownership of 12,264,703 Zimmer Biomet common shares, equal to
The certification specifies the position is held in the ordinary course of business and not for changing or influencing control, indicating a passive investment stance under Schedule 13G. Future ownership updates, if any, would typically appear in subsequent beneficial ownership filings rather than operational disclosures.